Similarly, we observed repression of Enhancer of Zeste 2 Polycomb Repressive Complex 2 Subunit (EZH2), which is a predicted target of miR-101-3p that has been linked to oncogenesis in CRC [27, 28]. The gene discussed is EZH2; the disease is colorectal carcinoma.